The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.137
https://www.valueinhealthjournal.com/article/S1098-3015(13)02042-1/fulltext
Title :
The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02042-1&doi=10.1016/j.jval.2013.08.137
First page :
A345
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
123